Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Current Cancer Drug Targets|April 27, 2013
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy?Alessandra Dicitore, Michele Caraglia, Annamaria Colao, et al.
Current Cancer Drug Targets|June 25, 2016
Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other TumorsAlessandro Federico, Silvia Zappavigna, Marcello Dallio, et al.
Current Pharmaceutical Biotechnology|April 19, 2016
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern UlyssesSilvia Zappavigna, Gabriella Misso, Annarita Falanga, et al.
In Vivo (Athens, Greece)|September 12, 2015
Silybin-Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative StressAlessandro Federico, Marcello Dallio, Giovanni DI Fabio, et al.
Endocrine|January 12, 2015
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell linesConcetta Paola Ilisso, Maria Castellano, Silvia Zappavigna, et al.
Expert Opinion on Biological Therapy|June 7, 2013
Emerging pathways as individualized therapeutic target of multiple myelomaGabriella Misso, Silvia Zappavigna, Maria Castellano, et al.
International Journal of Molecular Sciences|April 15, 2020
Anti-Inflammatory Drugs as Anticancer AgentsSilvia Zappavigna, Alessia Maria Cossu, Anna Grimaldi, et al.
Biochimica Et Biophysica Acta|October 15, 2013
Interleukin 18: friend or foe in cancerGiuseppe Palma, Antonio Barbieri, Sabrina Bimonte, et al.
Pageof 10